Chaime Orlev

Chaime Orlev is serving as our Chief Financial Officer since December 2017. Prior to joining us, he served as Chief Financial Officer and VP Finance and Administration of Bioblast Pharma Ltd (NASDAQ:ORPN) from 2016 to 2017. Prior to that, Mr. Orlev served in various finance positions, in the biotech industry, including VP Finance and Administration of Chiasma Inc. (NASDAQ: CHMA), Chief Financial Officer of Oramed Pharmaceuticals Inc. (NASDAQ: ORMP), and Chief Financial Officer of Gammacan Inc. Mr. Orlev also served as VP Finance and Chief Financial Officer of Huntleigh USA Corporation. Mr. Orlev received his M.B.A. from the Leon Recanati Graduate School of Business Administration at the Tel Aviv University and a B.A. in Business Administration from the College of Business in Israel. Mr. Orlev is a Certified Public Accountant under the laws of the state of Israel.